Patents by Inventor Iris Kuss

Iris Kuss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260256742
    Abstract: Described herein are methods of treating patients with biochemical recurrence of hormone-sensitive prostate cancer using a drug product comprising an androgen receptor inhibitor, such as darolutamide.
    Type: Application
    Filed: March 15, 2024
    Publication date: September 3, 2026
    Inventors: Lucia TRANDAFIR, Patricia COLE, Iris KUSS
  • Publication number: 20130183268
    Abstract: The present invention relates to drug combinations and pharmaceutical compositions for treating hyperproliferative disorders such as cancer including non-small cell lung carcinoma, said drug combination comprising (1) a fluoro-substituted-diaryl urea of Formula (I), (2) at least one antifolate and optionally (3) at least one platinum complex antineoplastic nucleic acid binding agent, where any of these components can be present in the form of a pharmaceutically acceptable salt or other derivative thereof.
    Type: Application
    Filed: July 19, 2011
    Publication date: July 18, 2013
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Olaf Christensen, Iris Kuss